Novelix Pharmaceuticals Ltd. Stock price: Live updates

₹55.55

3.18% (1.71)

Market Cap

₹114 Cr.

P/E

62.17

Key Ratios

Edit Ratio's

Market cap

114 Cr

62.17

Prom Holding

49.43 %

ROE (%)

0.48

ROCE (%)

0.71

Div Yield (%)

Sales

127 Cr

OPM (%)

1.90 %

Debt to Equity

Institutions

Individual < 2 lac

7.02 %

No. of Shareholders

2,975

Edit Ratio's

About

Trimurthi Limited is a Public Limited Company having Registered Office situated at Hyderabad, … Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

1 No Data

Insufficient data to analyse

Accounting & Shareholding

Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Contingent Liabilities

Unable to calculate due to limited data

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
ROE

Net profit margin is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Working Capital

Working capital of the company seems to be under control
Sales Growth

Sales of the company has grown at a good pace
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Debt

Company might have issues servicing its debt
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Novelix Pharmaceuticals Ltd. Business

What does Novelix Pharma do?

Trimurthi Limited, a Public Limited Company based in Hyderabad, Telangana, is engaged in trading pharmaceuticals, related products, shares, and securities.

Who are the competitors of Novelix Pharma?

Novelix Pharma major competitors are Anand Rayons, Positron Energy, Ashnisha Industries, Thacker & Co, Sunrise Efficient, TCI Industries, Bhilwara Spinners.
Market Cap of Novelix Pharma is ₹114 Crs.
While the median market cap of its peers are ₹117 Crs.

Is Novelix Pharma financially stable compared to its competitors?

Novelix Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Novelix Pharma is 9.34 and is ranked 4 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Claude

Discussions & Analysis

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

Novelix Pharmaceuticals Ltd.

Novelix Pharmaceuticals Ltd.

Key Ratios

About

Timeline

Company Timeline

Custom financial statement

Forensics

10 Yes

2 Neutral

4 No

1 No Data

Accounting & Shareholding

Depreciation Effect

Other Income

Pledge

Retail Holding

Revenue Recognition

Promoter Holding

Contingent Liabilities

Price & Performance

Capex vs ROCE

ROE

Share price

Working Capital

Sales Growth

Balance Sheet Strength

Current vs Historic Valuation

Debt

Margin Stability

ROCE Strength

Revenue mix

Product Wise Break-Up

UNLOCK PREMIUM

Peer Comparison

FAQs on Novelix Pharmaceuticals Ltd. Business

What does Novelix Pharma do?

Who are the competitors of Novelix Pharma?

Is Novelix Pharma financially stable compared to its competitors?

Company Filing

Discussions & Analysis

SIGN UP FOR FREE